State of Wisconsin Investment Board’s Repare Therapeutics RPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,618
Closed -$165K 2540
2023
Q3
$165K Sell
13,618
-152
-1% -$1.57K ﹤0.01% 2295
2023
Q2
$146K Sell
13,770
-893
-6% -$9.2K ﹤0.01% 2190
2023
Q1
$144K Sell
14,663
-1,593
-10% -$18.3K ﹤0.01% 2333
2022
Q4
$239K Sell
16,256
-1,141
-7% -$17.1K ﹤0.01% 2180
2022
Q3
$211K Sell
17,397
-1,030
-6% -$13.3K ﹤0.01% 2381
2022
Q2
$258K Buy
18,427
+4,527
+33% +$53.3K ﹤0.01% 2383
2022
Q1
$198K Buy
+13,900
New +$206K ﹤0.01% 2183

Other funds holding RPTX

State of Wisconsin Investment Board's RPTX Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 13,618 shares — an estimated $165K sold.

State of Wisconsin Investment Board first reported a position in RPTX in Q1 2022 and held it in 7 quarters. The position peaked at $258K in Q2 2022. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 13,618 Repare Therapeutics shares in Q4 2023, an estimated $165K.
  • State of Wisconsin Investment Board first reported a position in Repare Therapeutics in Q1 2022 and held it in 7 quarters.
  • State of Wisconsin Investment Board's Repare Therapeutics position peaked at $258K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.